○Luis Querol1,2 (1.Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 2.Centro para la Investigacion en Red en Enfermedades Raras - CIBERER, Spain)
Session information
Symposium
[S-35] Symposium 35 Disassemble "CIDP"! Reclassification of "CIDP" based on molecular autoimmune mechanism
Fri. May 21, 2021 2:40 PM - 4:40 PM Room 07 (ICC Kyoto 1F Room D)
Chair:Koike Haruki(Department of Neurology, Nagoya University Graduate School of Medicine),Yamasaki Ryo(Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University)
In recent years, in chronic inflammatory demyelinating polyradiculitis (CIDP), autoreactive antibodies have been found in succession in a part of the patients, and the unique mechanism of each antibody is becoming clear. In this session, we will discuss disease classification based on a new molecular mechanism and treatment selection based on it, without being bound by the conventional clinical distinction of GBS / CIDP.
○Haruki Koike (Department of Neurology, Nagoya University Graduate School of Medicine, Japan)
○Motoi Kuwahara (Department of Neurology, Kindai University, Faculty of Medicine, Japan)
○Hidenori Ogata (Department of Neurology, Kyushu University Hospital, Japan)